Overall, our results, together with previous findings, suggest that the angiotensin converting enzyme inhibitor Cap might broadly inhibit stress-induced cardiomyopathy, which in turn might lead to improved longevity and reduced physiological frailty. The gene discussed is ACE; the disease is cardiomyopathy.